REFERENCES
- Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage disease. Am J Kidney Dis 1991; XVII: 29–33.
- Berns JS, Rudnick MR, Cohen RM. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 1992; 37: 264–267.
- Bernstein MS, Hunter RL, Yachnin S. Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia. N Engl J Med 1971; 284: 1135–1136.
- Buchwald D, Argyres S, Easterling RE, et al. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients. Nephron 1977; 18: 232–238.
- Cattran DC, Fenton SSA, Wilson DR, Oreopoulos D, Shimizu A, Richardson RM. A controlled trial of nandrolone decanoate in the treatment of uremic anemia. Kidney Int 1977; 12: 430–437.
- Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mostality from coronary heart disease. N Eng J Med 1993; 328: 1220–1225.
- Davies M, Muckle TJ, Cassells-Smith Webster D, Kerr DNS. Oxymetholone in the treatment of anemia in chronic renal failure. Br J Urol 1972; 44: 387–394.
- DeGowin RL, Lavender AR, Forland M, Charleston D, Gottschalk A. Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med 1970; 72: 913–918.
- Eschbach JW, Adamson JW. Improvement in the anemia of chronic renal failure with fluoxymesterone. Ann Intern Med 1973; 78: 527–532.
- Fried W, Jonason O, Lang G, Schwartz F. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses. Ann Intern Med 1973; 79: 823–827.
- von Hartitzsch B, Kerr DNS, Morley G, Marks B. Androgens in the anaemia of chronic renal failure. Nephron 1977; 18: 13–20.
- Hendler ED, Goffinet JA, Ross S, Longnecker RE, Bakovic V. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 1974; 291: 1046–1051.
- Johnson FL, Feagler JR, Lerner KG, et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet 1972; 2: 1273–1276.
- Kalmanti M, Dainiak N, Martino J, Dewey M, Kulkarni V, Howard D. Correlation of clinical and in vitro erythropoietic responses to androgens in renal failure. Kidney Int 1982; 22: 383–391.
- Mirahmadi MK, Vaziri ND, Gorman JT. Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) vs testosterone enanthate (TE). Trans Am Soc Artif Intern Organs 1979; 25: 449–453.
- Naik RB, Gibbons AR, Gyde OHB, Harris BR, Robinson BHB. Androgen tria in renal anemia (Abstract). Kidney Int 1978; 14: 109.
- Neff MS, Goldberg J, Slifkin RF, et al. A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 1981; 304: 871–875.
- Parker PA, Izard MW, Maher JF. Therapy of iron deficiency in patients on maintenance dialysis. Nephron 1979; 23: 181–186.
- Pascual J, Teruel JL, Marcén R, Liao F, Ortuo J. Blood pressure after three different forms of correction of anemia in hemodialysis. Int J Artif Organs 1992; 15: 393–396.
- Richardson JRJr, Weinstein MB. Erythropoietic response of dialyzed patients to testosterone administration. Ann Intern Med 1970; 73: 403–407.
- Shaldon S, Koch KM, Oppermann F, Patyna WD, Schoeppe W. Testosterone therapy for anaemia in maintenance dialysis. Br Med J 1971; 3: 212–214.
- Teruel JL, Quereda C, Martin E, Orofino L, Liao F, Ortuo J. Tratamiento de la anemia no ferropénica en hemodiálisis mediante anabolizantes. Nefrologia 1983; III: 273–278.
- Williams JS, Stein JH, Ferris ThH. Nandrolone decanoate therapy for patients receiving hemodialysis. Arch Intern Med 1974; 134: 289–292.
- Zevin D, Turani H, Cohen A, Levi J. Androgen-associated hepatoma in a hemodialysis patient. Nephron 29: 274–276, 1981.